Deregulated GSK3β activity in colorectal cancer

Its association with tumor cell survival and proliferation

Abbas Shakoori, Andrei Ougolkov, Wei Yu Zhi, Bin Zhang, Mohammad H. Modarressi, Daniel D Billadeau, Masayoshi Mai, Yutaka Takahashi, Toshinari Minamoto

Research output: Contribution to journalArticle

192 Citations (Scopus)

Abstract

Glycogen synthase kinase 3β (GSK3β) reportedly has opposing roles, repressing Wnt/β-catenin signaling on the one hand but maintaining cell survival and proliferation through the NF-κB pathway on the other. The present investigation was undertaken to clarify the roles of GSK3β in human cancer. In colon cancer cell lines and colorectal cancer patients, levels of GSK3β expression and amounts of its active form were higher in tumor cells than in their normal counterparts; these findings were independent of nuclear accumulation of β-catenin oncoprotein in the tumor cells. Inhibition of GSK3β activity by phosphorylation was defective in colorectal cancers but preserved in non-neoplastic cells and tissues. Strikingly, inhibition of GSK3β activity by chemical inhibitors and its expression by RNA interference targeting GSK3β induced apoptosis and attenuated proliferation of colon cancer cells in vitro. Our findings demonstrate an unrecognized role of GSK3β in tumor cell survival and proliferation other than its predicted role as a tumor suppressor, and warrant proposing this kinase as a potential therapeutic target in colorectal cancer.

Original languageEnglish (US)
Pages (from-to)1365-1373
Number of pages9
JournalBiochemical and Biophysical Research Communications
Volume334
Issue number4
DOIs
StatePublished - Sep 9 2005

Fingerprint

Glycogen Synthase Kinase 3
Tumors
Colorectal Neoplasms
Cell Survival
Cells
Cell Proliferation
Association reactions
Neoplasms
Catenins
Colonic Neoplasms
Phosphorylation
Oncogene Proteins
RNA Interference
Phosphotransferases
RNA
Tissue
Apoptosis
Cell Line

Keywords

  • β-catenin
  • Apoptosis
  • Cell survival
  • Colorectal cancer
  • Glycogen synthase kinase 3β
  • NF-κB
  • Phosphorylation
  • Proliferation
  • Therapeutic target
  • Wnt signaling

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Molecular Biology

Cite this

Deregulated GSK3β activity in colorectal cancer : Its association with tumor cell survival and proliferation. / Shakoori, Abbas; Ougolkov, Andrei; Zhi, Wei Yu; Zhang, Bin; Modarressi, Mohammad H.; Billadeau, Daniel D; Mai, Masayoshi; Takahashi, Yutaka; Minamoto, Toshinari.

In: Biochemical and Biophysical Research Communications, Vol. 334, No. 4, 09.09.2005, p. 1365-1373.

Research output: Contribution to journalArticle

Shakoori, Abbas ; Ougolkov, Andrei ; Zhi, Wei Yu ; Zhang, Bin ; Modarressi, Mohammad H. ; Billadeau, Daniel D ; Mai, Masayoshi ; Takahashi, Yutaka ; Minamoto, Toshinari. / Deregulated GSK3β activity in colorectal cancer : Its association with tumor cell survival and proliferation. In: Biochemical and Biophysical Research Communications. 2005 ; Vol. 334, No. 4. pp. 1365-1373.
@article{c2625497d34545c08e4e3c6272b5e11e,
title = "Deregulated GSK3β activity in colorectal cancer: Its association with tumor cell survival and proliferation",
abstract = "Glycogen synthase kinase 3β (GSK3β) reportedly has opposing roles, repressing Wnt/β-catenin signaling on the one hand but maintaining cell survival and proliferation through the NF-κB pathway on the other. The present investigation was undertaken to clarify the roles of GSK3β in human cancer. In colon cancer cell lines and colorectal cancer patients, levels of GSK3β expression and amounts of its active form were higher in tumor cells than in their normal counterparts; these findings were independent of nuclear accumulation of β-catenin oncoprotein in the tumor cells. Inhibition of GSK3β activity by phosphorylation was defective in colorectal cancers but preserved in non-neoplastic cells and tissues. Strikingly, inhibition of GSK3β activity by chemical inhibitors and its expression by RNA interference targeting GSK3β induced apoptosis and attenuated proliferation of colon cancer cells in vitro. Our findings demonstrate an unrecognized role of GSK3β in tumor cell survival and proliferation other than its predicted role as a tumor suppressor, and warrant proposing this kinase as a potential therapeutic target in colorectal cancer.",
keywords = "β-catenin, Apoptosis, Cell survival, Colorectal cancer, Glycogen synthase kinase 3β, NF-κB, Phosphorylation, Proliferation, Therapeutic target, Wnt signaling",
author = "Abbas Shakoori and Andrei Ougolkov and Zhi, {Wei Yu} and Bin Zhang and Modarressi, {Mohammad H.} and Billadeau, {Daniel D} and Masayoshi Mai and Yutaka Takahashi and Toshinari Minamoto",
year = "2005",
month = "9",
day = "9",
doi = "10.1016/j.bbrc.2005.07.041",
language = "English (US)",
volume = "334",
pages = "1365--1373",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Academic Press Inc.",
number = "4",

}

TY - JOUR

T1 - Deregulated GSK3β activity in colorectal cancer

T2 - Its association with tumor cell survival and proliferation

AU - Shakoori, Abbas

AU - Ougolkov, Andrei

AU - Zhi, Wei Yu

AU - Zhang, Bin

AU - Modarressi, Mohammad H.

AU - Billadeau, Daniel D

AU - Mai, Masayoshi

AU - Takahashi, Yutaka

AU - Minamoto, Toshinari

PY - 2005/9/9

Y1 - 2005/9/9

N2 - Glycogen synthase kinase 3β (GSK3β) reportedly has opposing roles, repressing Wnt/β-catenin signaling on the one hand but maintaining cell survival and proliferation through the NF-κB pathway on the other. The present investigation was undertaken to clarify the roles of GSK3β in human cancer. In colon cancer cell lines and colorectal cancer patients, levels of GSK3β expression and amounts of its active form were higher in tumor cells than in their normal counterparts; these findings were independent of nuclear accumulation of β-catenin oncoprotein in the tumor cells. Inhibition of GSK3β activity by phosphorylation was defective in colorectal cancers but preserved in non-neoplastic cells and tissues. Strikingly, inhibition of GSK3β activity by chemical inhibitors and its expression by RNA interference targeting GSK3β induced apoptosis and attenuated proliferation of colon cancer cells in vitro. Our findings demonstrate an unrecognized role of GSK3β in tumor cell survival and proliferation other than its predicted role as a tumor suppressor, and warrant proposing this kinase as a potential therapeutic target in colorectal cancer.

AB - Glycogen synthase kinase 3β (GSK3β) reportedly has opposing roles, repressing Wnt/β-catenin signaling on the one hand but maintaining cell survival and proliferation through the NF-κB pathway on the other. The present investigation was undertaken to clarify the roles of GSK3β in human cancer. In colon cancer cell lines and colorectal cancer patients, levels of GSK3β expression and amounts of its active form were higher in tumor cells than in their normal counterparts; these findings were independent of nuclear accumulation of β-catenin oncoprotein in the tumor cells. Inhibition of GSK3β activity by phosphorylation was defective in colorectal cancers but preserved in non-neoplastic cells and tissues. Strikingly, inhibition of GSK3β activity by chemical inhibitors and its expression by RNA interference targeting GSK3β induced apoptosis and attenuated proliferation of colon cancer cells in vitro. Our findings demonstrate an unrecognized role of GSK3β in tumor cell survival and proliferation other than its predicted role as a tumor suppressor, and warrant proposing this kinase as a potential therapeutic target in colorectal cancer.

KW - β-catenin

KW - Apoptosis

KW - Cell survival

KW - Colorectal cancer

KW - Glycogen synthase kinase 3β

KW - NF-κB

KW - Phosphorylation

KW - Proliferation

KW - Therapeutic target

KW - Wnt signaling

UR - http://www.scopus.com/inward/record.url?scp=23044444841&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23044444841&partnerID=8YFLogxK

U2 - 10.1016/j.bbrc.2005.07.041

DO - 10.1016/j.bbrc.2005.07.041

M3 - Article

VL - 334

SP - 1365

EP - 1373

JO - Biochemical and Biophysical Research Communications

JF - Biochemical and Biophysical Research Communications

SN - 0006-291X

IS - 4

ER -